Insights/ News/ R&D Genentech signs deal with Parvus to tackle inflammatory diseases Richard Staines Parvus, Roche 0 Comment Canada’s Parvus Therapeutics has signed a deal with Roche’s Genentech unit to develop, manufacture and market drugs for Share X Genentech signs deal with Parvus to tackle inflammatory diseases https://pharmaphorum.com/news/genentech-signs-deal-with-parvus-to-tackle-inflammatory-diseases/
